Condition

Inflammation (3)

Covid19 (2)

Acute Kidney Injury (1)

Kidney Diseases (1)

Outcome, Fatal (1)

Respiratory Failure (1)

Rheumatoid Arthritis (1)

SARS-CoV Infection (1)

Overall Status

Recruiting (2)

Terminated (1)

Phase

phase 2 (1)

Sponsor

University of Michigan (2)

Novo Nordisk A/S (1)

Collaborator

Charite University, Berlin, Germany (1)

Copenhagen University Hospital, Hvidovre (1)

Heinrich-Heine University, Duesseldorf (1)

Rush University (1)

University of Athens (1)

University of Thessaly (1)

Intervention

biomarkers of inflammation (1)

nnc0109-0012 (1)

placebo (1)

supar, c-reactive protein, ferritin, d-dimer, procalcitonin, interleukin-6, lactate dehydrogenase (1)

Study Documents

Intervention Type

diagnostic test (2)

drug (1)

Funder Type

Other (2)

Industry (1)

Study Type

Observational (2)

Interventional (1)

Inflammation

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

International Study of Inflammation in COVID-19

Recruiting

Covid19
+4 more

SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase

Ann Arbor, Michigan

University of Michigan

Aug 17, 2022

Outcomes of Patients Hospitalized for COVID-19

Recruiting

Covid19
+3 more

Biomarkers of inflammation

Ann Arbor, Michigan

University of Michigan

Aug 9, 2022

Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )

Terminated

Inflammation
Rheumatoid Arthritis

NNC0109-0012
placebo

Huntsville, Alabama
+163 more

Sep 3, 2018